Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy
about
Prediction of multidimensional drug dose responses based on measurements of drug pairs.Preclinical activity of melflufen (J1) in ovarian cancer.New in vitro system to predict chemotherapeutic efficacy of drug combinations in fresh tumor samples.In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia.Institutional profile: the national Swedish academic drug discovery & development platform at SciLifeLab.Prediction of drug cocktail effects when the number of measurements is limited.Why a Special Issue on Acoustic Liquid Handling?
P2860
Q37264069-3D631D27-DA2C-40B2-8172-19576DAC3033Q37644866-266FB573-0036-44BE-BBB3-306C5916872CQ37680702-AE906135-367E-4303-A9B4-557E3FE90814Q37701604-46E8917F-3902-4E55-9765-DEB628A9CF8EQ42335275-FBAC9959-DE48-407E-816F-A9D4FCF8AB88Q43727504-604E18CB-78B1-4661-9461-168D1FC6A801Q50234747-D65B52A3-4F7C-45FF-9E4E-5FCE777BA417
P2860
Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy
description
im Februar 2016 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2016
@uk
name
Ex Vivo Assessment of Drug Act ...... is for Tailored Cancer Therapy
@en
Ex Vivo Assessment of Drug Act ...... is for Tailored Cancer Therapy
@nl
type
label
Ex Vivo Assessment of Drug Act ...... is for Tailored Cancer Therapy
@en
Ex Vivo Assessment of Drug Act ...... is for Tailored Cancer Therapy
@nl
prefLabel
Ex Vivo Assessment of Drug Act ...... is for Tailored Cancer Therapy
@en
Ex Vivo Assessment of Drug Act ...... is for Tailored Cancer Therapy
@nl
P2860
P50
P356
P1476
Ex Vivo Assessment of Drug Act ...... is for Tailored Cancer Therapy
@en
P2093
Claes R. Andersson
Kristin Blom
P2860
P304
P356
10.1177/2211068215598117
P577
2016-02-01T00:00:00Z